174 related articles for article (PubMed ID: 1970224)
1. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder.
McDougle CJ; Goodman WK; Price LH; Delgado PL; Krystal JH; Charney DS; Heninger GR
Am J Psychiatry; 1990 May; 147(5):652-4. PubMed ID: 1970224
[TBL] [Abstract][Full Text] [Related]
2. A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy.
McDougle CJ; Price LH; Goodman WK; Charney DS; Heninger GR
J Clin Psychopharmacol; 1991 Jun; 11(3):175-84. PubMed ID: 1820757
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial.
Bogetto F; Bellino S; Vaschetto P; Ziero S
Psychiatry Res; 2000 Oct; 96(2):91-8. PubMed ID: 11063782
[TBL] [Abstract][Full Text] [Related]
4. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics.
McDougle CJ; Goodman WK; Leckman JF; Lee NC; Heninger GR; Price LH
Arch Gen Psychiatry; 1994 Apr; 51(4):302-8. PubMed ID: 8161290
[TBL] [Abstract][Full Text] [Related]
5. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
Jenike MA; Hyman S; Baer L; Holland A; Minichiello WE; Buttolph L; Summergrad P; Seymour R; Ricciardi J
Am J Psychiatry; 1990 Sep; 147(9):1209-15. PubMed ID: 2143637
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.
McDougle CJ; Epperson CN; Pelton GH; Wasylink S; Price LH
Arch Gen Psychiatry; 2000 Aug; 57(8):794-801. PubMed ID: 10920469
[TBL] [Abstract][Full Text] [Related]
8. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.
Goodman WK; Price LH; Delgado PL; Palumbo J; Krystal JH; Nagy LM; Rasmussen SA; Heninger GR; Charney DS
Arch Gen Psychiatry; 1990 Jun; 47(6):577-85. PubMed ID: 2112374
[TBL] [Abstract][Full Text] [Related]
9. Fluvoxamine treatment of coincident autistic disorder and obsessive-compulsive disorder: a case report.
McDougle CJ; Price LH; Goodman WK
J Autism Dev Disord; 1990 Dec; 20(4):537-43. PubMed ID: 2126264
[TBL] [Abstract][Full Text] [Related]
10. [The role of drugs in the treatment of obsessive-compulsive disorders].
den Boer JA; Westenberg HG
Ned Tijdschr Geneeskd; 1990 Mar; 134(10):503-4. PubMed ID: 2107405
[No Abstract] [Full Text] [Related]
11. Serotonergic antidepressants and obsessive-compulsive disorder.
Cialdella P; Boissel JP
Am J Psychiatry; 1991 Oct; 148(10):1415-6. PubMed ID: 1832819
[No Abstract] [Full Text] [Related]
12. Treatment of depersonalization with serotonin reuptake blockers.
Hollander E; Liebowitz MR; DeCaria C; Fairbanks J; Fallon B; Klein DF
J Clin Psychopharmacol; 1990 Jun; 10(3):200-3. PubMed ID: 2115893
[TBL] [Abstract][Full Text] [Related]
13. Clozapine in treatment-refractory obsessive-compulsive disorder with comorbid schizotypal personality disorder.
Poyurovsky M
Isr J Psychiatry Relat Sci; 2008; 45(3):219-20. PubMed ID: 19398826
[No Abstract] [Full Text] [Related]
14. Treatment of severe obsessive-compulsive disorder with fluvoxamine.
Price LH; Goodman WK; Charney DS; Rasmussen SA; Heninger GR
Am J Psychiatry; 1987 Aug; 144(8):1059-61. PubMed ID: 3111279
[TBL] [Abstract][Full Text] [Related]
15. Aripiprazole treatment in an adolescent patient with chronic motor tic disorder and treatment-resistant obsessive-compulsive disorder.
Lai CH
Int J Neuropsychopharmacol; 2009 Oct; 12(9):1291-3. PubMed ID: 19706223
[No Abstract] [Full Text] [Related]
16. Fenfluramine augmentation of serotonin reuptake blockade antiobsessional treatment.
Hollander E; DeCaria CM; Schneier FR; Schneier HA; Liebowitz MR; Klein DF
J Clin Psychiatry; 1990 Mar; 51(3):119-23. PubMed ID: 2106515
[TBL] [Abstract][Full Text] [Related]
17. Fluvoxamine treatment of obsessive-compulsive disorder.
Perse TL; Greist JH; Jefferson JW; Rosenfeld R; Dar R
Am J Psychiatry; 1987 Dec; 144(12):1543-8. PubMed ID: 3120604
[TBL] [Abstract][Full Text] [Related]
18. Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder.
McDougle CJ; Goodman WK; Price LH
J Clin Psychiatry; 1994 Mar; 55 Suppl():24-31. PubMed ID: 7521326
[TBL] [Abstract][Full Text] [Related]
19. [Obsessive-compulsive symptoms associated with panic disorder. Predictive factor of a good therapeutic response to fluvoxamine].
Servant D; Bailly D; Le Seac'h H; Parquet PJ
Encephale; 1990; 16 Spec No():359-62. PubMed ID: 2120029
[TBL] [Abstract][Full Text] [Related]
20. Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases.
McDougle CJ; Fleischmann RL; Epperson CN; Wasylink S; Leckman JF; Price LH
J Clin Psychiatry; 1995 Nov; 56(11):526-8. PubMed ID: 7592506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
